enVVeno Medical Corp Depreciation
enVVeno Medical Corp (NVNO) reported Depreciation of $100.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-26
- enVVeno Medical Corp depreciation for the quarter ending 2025-03-31 was $100.00K, a 0.00% change year-over-year.
- enVVeno Medical Corp depreciation for the quarter ending 2024-03-31 was $100.00K, a 0.00% change year-over-year.
- enVVeno Medical Corp depreciation for the quarter ending 2023-03-31 was $100.00K, a 0.00% change year-over-year.
- enVVeno Medical Corp depreciation for the quarter ending 2022-03-31 was $100.00K, a 0.00% change year-over-year.
- enVVeno Medical Corp depreciation for fiscal 2025 was $100.00K, a 50.00% decline from fiscal 2024.
- enVVeno Medical Corp depreciation for fiscal 2024 was $200.00K, a 0.00% change from fiscal 2023.
- enVVeno Medical Corp depreciation for fiscal 2023 was $200.00K, a 0.00% change from fiscal 2022.
- enVVeno Medical Corp depreciation for fiscal 2022 was $200.00K, a 100.00% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $100.00K 10-K · filed 2026-03-26 | |||||
| 2025-03-31 | $100.00K 10-Q · filed 2025-04-30 | |||||
| 2024-12-31 | $200.00K 10-K · filed 2026-03-26 | |||||
| 2024-03-31 | $100.00K 10-Q · filed 2025-04-30 | |||||
| 2023-12-31 | $200.00K 10-K · filed 2025-02-28 | |||||
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-08 | |||||
| 2022-12-31 | $200.00K 10-K · filed 2024-02-29 | |||||
| 2022-03-31 | $100.00K 10-Q · filed 2023-04-28 | $155.92K derived: sum of 2 quarters · filed 2023-04-28 | $140.94K derived: sum of 3 quarters · filed 2023-04-28 | $100.00K derived: sum of 4 quarters · filed 2023-04-28 | ||
| 2021-12-31 | $55.92K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $40.94K derived: sum of 2 quarters · filed 2023-03-02 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | $100.00K 10-K · filed 2023-03-02 | ||
| 2021-09-30 | -$14.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$55.92K derived: sum of 2 quarters · filed 2021-11-12 | $44.08K 10-Q · filed 2021-11-12 | $77.22K derived: sum of 4 quarters · filed 2022-04-29 | ||
| 2021-06-30 | -$40.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $59.06K 10-Q · filed 2021-08-11 | $92.20K derived: sum of 3 quarters · filed 2022-04-29 | $114.10K derived: sum of 4 quarters · filed 2022-04-29 | ||
| 2021-03-31 | $100.00K 10-Q · filed 2022-04-29 | $27.62K 10-Q · filed 2021-05-12 | $133.14K derived: sum of 2 quarters · filed 2022-04-29 | $155.04K derived: sum of 3 quarters · filed 2022-04-29 | $180.32K derived: sum of 4 quarters · filed 2022-04-29 | |
| 2020-12-31 | $33.14K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $55.04K derived: sum of 2 quarters · filed 2022-03-28 | $80.32K derived: sum of 3 quarters · filed 2022-03-28 | $100.00K 10-K · filed 2022-03-28 | $97.55K 10-K · filed 2021-03-31 | |
| 2020-09-30 | $21.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $47.18K derived: sum of 2 quarters · filed 2021-11-12 | $66.86K 10-Q · filed 2021-11-12 | $86.05K derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $25.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $44.96K 10-Q · filed 2021-08-11 | $64.15K derived: sum of 3 quarters · filed 2021-08-11 | $79.83K derived: sum of 4 quarters · filed 2021-08-11 | ||
| 2020-03-31 | $19.68K 10-Q · filed 2021-05-12 | $38.87K derived: sum of 2 quarters · filed 2021-05-12 | $54.55K derived: sum of 3 quarters · filed 2021-05-12 | $62.63K derived: sum of 4 quarters · filed 2021-05-12 | ||
| 2019-12-31 | $19.19K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $34.87K derived: sum of 2 quarters · filed 2021-03-31 | $42.95K derived: sum of 3 quarters · filed 2021-03-31 | $46.02K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $15.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-17 | $23.76K derived: sum of 2 quarters · filed 2020-11-17 | $26.83K 10-Q · filed 2020-11-17 | $29.63K derived: sum of 4 quarters · filed 2020-11-17 | ||
| 2019-06-30 | $8.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $11.15K 10-Q · filed 2020-08-14 | $13.95K derived: sum of 3 quarters · filed 2020-08-14 | $16.50K derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | $3.06K 10-Q · filed 2020-06-08 | $5.87K derived: sum of 2 quarters · filed 2020-06-08 | $8.42K derived: sum of 3 quarters · filed 2020-06-08 | $10.80K derived: sum of 4 quarters · filed 2020-06-08 | ||
| 2018-12-31 | $2.80K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-18 | $5.35K derived: sum of 2 quarters · filed 2020-03-18 | $7.73K derived: sum of 3 quarters · filed 2020-03-18 | $10.11K 10-K · filed 2020-03-18 | ||
| 2018-09-30 | $2.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $4.93K derived: sum of 2 quarters · filed 2019-10-31 | $7.31K 10-Q · filed 2019-10-31 | |||
| 2018-06-30 | $2.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $4.76K 10-Q · filed 2019-08-05 | ||||
| 2018-03-31 | $2.38K 10-Q · filed 2019-05-09 | |||||
| 2017-12-31 | $15.90K 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |